CN104825651A - Traditional Chinese medicine composition for treating rheumatic arthralgia - Google Patents

Traditional Chinese medicine composition for treating rheumatic arthralgia Download PDF

Info

Publication number
CN104825651A
CN104825651A CN201510205541.2A CN201510205541A CN104825651A CN 104825651 A CN104825651 A CN 104825651A CN 201510205541 A CN201510205541 A CN 201510205541A CN 104825651 A CN104825651 A CN 104825651A
Authority
CN
China
Prior art keywords
parts
herba
chinese medicine
medicine composition
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201510205541.2A
Other languages
Chinese (zh)
Inventor
田丽华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zibo Qidingli Patent Information Consulting Co Ltd
Original Assignee
Zibo Qidingli Patent Information Consulting Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zibo Qidingli Patent Information Consulting Co Ltd filed Critical Zibo Qidingli Patent Information Consulting Co Ltd
Priority to CN201510205541.2A priority Critical patent/CN104825651A/en
Publication of CN104825651A publication Critical patent/CN104825651A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a traditional Chinese medicine composition for treating rheumatic arthralgia. The traditional Chinese medicine composition is composed of the following raw materials in parts by weight: 15 parts of pteris semipinnata, 12 parts of elatostema ichangense, 10 parts of radix codonopsis, 10 parts of poria cocos, 10 parts of phryma leptostachya, 15 parts of cassia twig, 15 parts of dictamni cortex, 6 parts of phellodendron, 10 parts of rhizoma atractylodis, 10 parts of buck grass, 5 parts of scorpion, 10 parts of eupatorium, 15 parts of broom cypress fruit, 15 parts of dandelion, 15 parts of wolfberry, and 5 parts of licorice. The provided traditional Chinese medicine composition can treat rheumatic arthralgia.

Description

A kind of Chinese medicine composition for the treatment of rheumatism numbness
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine composition and the preparation method and application that treat rheumatism numbness.
Background technology
Rheumatism numbness waits exopathogen invasion because wind and cold is damp and hot, impatency meridians joint, QI-blood circulation is smooth, with general joint be migrans red, swell, weigh, pain is for main clinical manifestation.Normal finger rheumatic arthritis.Lack effective medicine at present.
Summary of the invention
Goal of the invention: in order to solve the problem, the object of the present invention is to provide a kind of Chinese medicine composition and the preparation method and application that treat rheumatism numbness.
Technical scheme: the object of the invention is by following scheme realize:
Treat a Chinese medicine composition for rheumatism numbness, it is prepared by the raw material of following parts by weight: Herba Pteridis Semipinnatae 15 parts, Herba Caryopteridis Terniflorae 12 parts, Radix Codonopsis 10 parts, 10 parts, Poria, Herba speranskiae tuberculatae 10 parts, Ramulus Cinnamomi 15 parts, Cortex Dictamni 15 parts, Cortex Phellodendri 6 parts, Rhizoma Atractylodis 10 parts, Herba Lycopodii 10 parts, Scorpio 5 parts, Herba Eupatorii 10 parts, the Fructus Kochiae 15 parts, Herba Taraxaci 15 parts, Fructus Lycii 15 parts, 5 parts, Radix Glycyrrhizae.
The application of Chinese medicine composition in the medicine of preparation treatment rheumatism numbness of described treatment rheumatism numbness.
Herba Caryopteridis Terniflorae in the present invention, Latin is called Elatostema ichangense H.Schroter, belongs to Urticales, Urticaceae perennial herb.Deliver cold expelling, lung qi dispersing cough-relieving, promoting blood flow to regulate menstruation.For cold cough, chronic bronchitis, pertussis, stimulates the menstrual flow, puerperal abdonimal pain; Knife injury is controlled in external, burn and scald, venom.The present invention is with all herbal medicine.Herba Pteridis Semipinnatae is one of plant in Pteridaceae Polypodiales.The uprightly short or tiltedly life of stem, tool scale, leafage is raw; The long 20-35 centimetre of petiole, bronzing; Petiole ovum shape lanceolar, long 20-40 centimetre, wide 8-18 centimetre, two times pinniform drastic cracks; The wide lanceolar of top accessory pinna, long 7-11 centimetre, wide 3-4 centimetre, pinniform drastic crack; Side accessory pinna 3-7 couple, the full edge in upside to irregular plumage splits, the pinniform drastic crack of downside in rule; Sliver is linear, edge sawtooth shape; Sporangiorus is along accessory pinna marginal distribution.Classification system: Pterissemipinnata L., heat-clearing and toxic substances removing, reducing swelling and alleviating pain.For bacillary dysentery, acute enteritis, icterohepatitis, conjunctivitis; Traumatic injury is controlled in external, traumatic hemorrhage, skin infection furuncle and phyma, eczema, venom.The present invention is with all herbal medicine.All the other medicines all meet standards of pharmacopoeia or are documented in Chinese medicine voluminous dictionary.
Beneficial effect: Herba Pteridis Semipinnatae of the present invention, Herba Caryopteridis Terniflorae heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling are monarch drug, Radix Codonopsis, Poria, Herba speranskiae tuberculatae, Ramulus Cinnamomi, Cortex Dictamni, Cortex Phellodendri, Rhizoma Atractylodis, Herba Lycopodii, Scorpio, Herba Eupatorii, Herba Taraxaci, Fructus Lycii QI invigorating, dampness are brought down a fever, warming the meridian and promoting blood circulation, spleen invigorating is ministerial drug, the Fructus Kochiae, Radix Glycyrrhizae are adjuvant, coordinating the actions of various ingredients in a prescription, obtained medicine can safe and effective treatment rheumatism numbness.
Detailed description of the invention
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as that the scope of the above-mentioned theme of the present invention is only limitted to following example, all technology realized based on foregoing of the present invention all belong to scope of the present invention.
1. prepare embodiment
1.1 take Herba Pteridis Semipinnatae 15g, Herba Caryopteridis Terniflorae 12g, Radix Codonopsis 10g, Poria 10g, Herba speranskiae tuberculatae 10g, Ramulus Cinnamomi 15g, Cortex Dictamni 15g, Cortex Phellodendri 6g, Rhizoma Atractylodis 10g, Herba Lycopodii 10g, Scorpio 5g, Herba Eupatorii 10g, Fructus Kochiae 15g, Herba Taraxaci 15g, Fructus Lycii 15g, Radix Glycyrrhizae 5g, add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, incapsulate shell, the capsule of adult normal's 1 day consumption must be met.Be used for the treatment of rheumatism numbness.Oral, every bu is taken for twice sooner or later.
1.2 take Herba Pteridis Semipinnatae 15g, Herba Caryopteridis Terniflorae 12g, Radix Codonopsis 10g, Poria 10g, Herba speranskiae tuberculatae 10g, Ramulus Cinnamomi 15g, Cortex Dictamni 15g, Cortex Phellodendri 6g, Rhizoma Atractylodis 10g, Herba Lycopodii 10g, Scorpio 5g, Herba Eupatorii 10g, Fructus Kochiae 15g, Herba Taraxaci 15g, Fructus Lycii 15g, Radix Glycyrrhizae 5g, add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, add 50g starch, technique is granulated routinely, must meet the granule of adult normal's 1 day consumption.Be used for the treatment of rheumatism numbness.Oral, every bu is taken for twice sooner or later.
1.3 take Herba Pteridis Semipinnatae 15g, Herba Caryopteridis Terniflorae 12g, Radix Codonopsis 10g, Poria 10g, Herba speranskiae tuberculatae 10g, Ramulus Cinnamomi 15g, Cortex Dictamni 15g, Cortex Phellodendri 6g, Rhizoma Atractylodis 10g, Herba Lycopodii 10g, Scorpio 5g, Herba Eupatorii 10g, Fructus Kochiae 15g, Herba Taraxaci 15g, Fructus Lycii 15g, Radix Glycyrrhizae 5g, add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, add 50g starch, technique is granulated routinely, and tabletting, can obtain the tablet meeting adult normal's 1 day consumption.Be used for the treatment of rheumatism numbness.Oral, every bu is taken for twice sooner or later.
2. the present invention is to the clinical research of rheumatism numbness
2.1 physical data: inventor collects the out-patient of 50 routine rheumatism numbness altogether between in August ,-2013 in June, 2012, age 46-68 year, course of disease 1-4.Be divided at random: treatment group 25 example, blank group 25 example.The two groups of data such as age, state of an illness there was no significant differences, have comparability.
2.2 diagnostic criterias:
2.2.1 walk to alter pain based on the large joint of extremity, companion weigh, miserable, numb, joint joint stuffiness.There is the disease such as aversion to cold, heating more.
2.2.2 there is pharyngalgia tonsillitis history before sick more, or paddle and drench with rain, occupy wetland history for a long time.
2.2.3 some patients can have low grade fever, extremity erythema iris, or erythema nodosum.Often can Cardiac Involvemant.
2.2.4 erythrocyte sedimentation rate speeds, and antistreptococcin " O " is greater than 500 units.
2.2.5 syndrome-classification
2.2.5.1 migratory arthralgia (ailment said due to cold or exposure wins partially): limbs joint myalgia, migration is indefinite, joint stuffiness, or sees fever with aversion to wind etc.Thin white fur of tongue, floating pulse.
2.2.5.2 arthralgia aggravated by cold (cold-evil wins partially): limbs joint pain is more acute, meets cold increasing the weight of, pain alleviated while getting warmth, and light night in daytime is heavy, and joint can not be bent and stretched, and sore spot is not red, and that touches is not hot.White, slippery and moist fur, stringy and tense pulse.
2.2.5.3 damp arthralgia (damp wins partially): limbs joint weighs aches, and sore spot is fixed, lower limb are very, or have swelling, numbness of the skin, and weather wet weather increases the weight of.White and greasy fur, relaxed and soft pulse.
2.2.5.4 pyretic arthralgia (pathogenic heat wins partially): onset is hurried, arthralgia, local is red and swollen scorching hot, and pain can not be touched, and joint stuffiness, obtains cold slightly easypro.There is fever and aversion to wind, hyperhidrosis, restlessness and thirst more.Red tongue with yellow fur, slippery and rapid pulse.
2.2.5.5 paralysis (QI and blood deficiency): with the passing of time the course of disease, does not heal repeatedly, arthralgia, time light time heavy.Yellowish complexion is simple and unadorned, cardiopalmus spontaneous perspiration, dizzy weak.Pale tongue, white and thin fur, soft pulse.
2.3 test method
2.3.1 the oral the present invention for the treatment of group is according to the obtained capsule of specific embodiment 1.1, sooner or later each once.30 days courses for the treatment of.
2.3.2 blank group oral placebo capsule, sooner or later respectively once.30 days courses for the treatment of.
2.4 criterions of therapeutical effect and therapeutic outcome
2.4.1 criterion of therapeutical effect
Recovery from illness: transference cure, joint motion is normal, and lab testing is normal.Take a turn for the better: symptom is clearly better, and lab testing is improved.Invalid: symptom and lab testing are without progress.
2.4.2 statistical result is treated in table 1.
Table 1 liang group comparitive study
Group n Recovery from illness Take a turn for the better Invalid Total effective rate (%)
Treatment group 25 11 14 5 90
Blank group 25 0 1 24 4
Visible, the medicine that the present invention obtains can safe and effective treatment rheumatism numbness.

Claims (2)

1. treat the Chinese medicine composition of rheumatism numbness for one kind, it is characterized in that, it is prepared by the raw material of following parts by weight: Herba Pteridis Semipinnatae 15 parts, Herba Caryopteridis Terniflorae 12 parts, Radix Codonopsis 10 parts, 10 parts, Poria, Herba speranskiae tuberculatae 10 parts, Ramulus Cinnamomi 15 parts, Cortex Dictamni 15 parts, Cortex Phellodendri 6 parts, Rhizoma Atractylodis 10 parts, Herba Lycopodii 10 parts, Scorpio 5 parts, Herba Eupatorii 10 parts, the Fructus Kochiae 15 parts, Herba Taraxaci 15 parts, Fructus Lycii 15 parts, 5 parts, Radix Glycyrrhizae.
2. treat the application of Chinese medicine composition in the medicine for the treatment of rheumatism numbness of rheumatism numbness as claimed in claim 1.
CN201510205541.2A 2015-04-26 2015-04-26 Traditional Chinese medicine composition for treating rheumatic arthralgia Withdrawn CN104825651A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510205541.2A CN104825651A (en) 2015-04-26 2015-04-26 Traditional Chinese medicine composition for treating rheumatic arthralgia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510205541.2A CN104825651A (en) 2015-04-26 2015-04-26 Traditional Chinese medicine composition for treating rheumatic arthralgia

Publications (1)

Publication Number Publication Date
CN104825651A true CN104825651A (en) 2015-08-12

Family

ID=53804101

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510205541.2A Withdrawn CN104825651A (en) 2015-04-26 2015-04-26 Traditional Chinese medicine composition for treating rheumatic arthralgia

Country Status (1)

Country Link
CN (1) CN104825651A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105296156A (en) * 2015-11-13 2016-02-03 李洋 Extraction method and applications of camphor wood oil essence

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101249151A (en) * 2008-04-10 2008-08-27 北京万寿通医药科技有限公司 Chinese medicine preparation for treating gout and rheumatism
CN101455732A (en) * 2007-12-12 2009-06-17 天津市中宝制药有限公司 Traditional Chinese medicine composition for treating arthralgia due to wind-dampness

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101455732A (en) * 2007-12-12 2009-06-17 天津市中宝制药有限公司 Traditional Chinese medicine composition for treating arthralgia due to wind-dampness
CN101249151A (en) * 2008-04-10 2008-08-27 北京万寿通医药科技有限公司 Chinese medicine preparation for treating gout and rheumatism

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105296156A (en) * 2015-11-13 2016-02-03 李洋 Extraction method and applications of camphor wood oil essence

Similar Documents

Publication Publication Date Title
CN104288426A (en) Traditional Chinese medicine lotion for treating senile cutaneous pruritus and preparation method thereof
CN103341066B (en) Chinese medicine oral liquid for treating hand-foot-mouth diseases of children and preparation method thereof
CN102552572B (en) Chinese medicine for treating appendicitis
CN105641564A (en) Medicine for treating gouty arthritis by combining oral administration and external application of traditional Chinese medicines
CN103083433A (en) Drug for treating rheumatism and rheumatoid sciatica
CN101028502A (en) Chinese-medicinal composition for treating difficult menstruation
CN104825651A (en) Traditional Chinese medicine composition for treating rheumatic arthralgia
CN104013816A (en) Pharmaceutical composition for treating esophagus cancer
CN103550615B (en) Traditional Chinese medicine for treating spleen-kidney deficiency scouring disease
CN104225405A (en) Chinese medicinal buccal tablet for treating respiratory tract infection and preparation method
CN104435676A (en) Chinese medicinal composition for treating rheumatic arthralgia as well as preparation method and application thereof
CN103948856A (en) Traditional Chinese medicament for treating artories and veims stasis syndrome chest stuffiness and pains
CN103520570A (en) Traditional Chinese medicine for treating liver depression forming fire syndrome type acne disease
CN102526527B (en) Chinese medicinal preparation for treating scarlet fever
CN105267296A (en) Traditional Chinese medicine for treating erythema nodosum
CN104688917A (en) Traditional Chinese medicine for curing anaphylactoid purpura
CN105148078A (en) Medicinal preparation used for treating oral ulcers
CN105055998A (en) Traditional Chinese medicine composition for treating rheumatic arthritis
CN104800401A (en) Traditional Chinese medicine composition for treating rheumatic arthritis
CN104524368A (en) Traditional Chinese medicine composition for treating urticaria as well as preparation method and application of traditional Chinese medicine composition
CN104857207A (en) Traditional Chinese medicine for treating rheumatic arthralgia
CN105012808A (en) Medicinal preparation for treating gout
CN105267399A (en) Medicine for treating cold-heat jumble symptom of rheumatoid arthritis
CN105079543A (en) Medicinal preparation for treating ovarian cyst
CN104524296A (en) Traditional Chinese medicine composition for treating summerheat-heat stirring wind syndrome pattern summerheat convulsive disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20150812

WW01 Invention patent application withdrawn after publication